route of administrationBLOOD-RETINAL BARRIERBLOCK-COPOLYMER HYDROGELSSUSTAINED-RELEASECELLULOSEPHNANOPARTICLESTEMPERATURERecently, the eye drug delivery system has received increasing attention. The in situ ophthalmic gel is a semisolid ophthalmic preparation that can be changed in the eyes immediately after ...
1. As a general rule, the duration of administration of this drug should be limited to the minimum period required for the treatment of the patient’s condition, after susceptibility of the microorganism to the drug has been confirmed, in order to prevent the emergence of drug-resistant ...
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70748-332 Route of Administration OPHTHALMIC Active Ingredient/Active Moiety Ingredient NameBasis of StrengthStrength PREDNISOLONE ACETATE (UNII: 8B2807733D) (PREDNISOLONE - UNII:9PHQ9Y1OLM) PREDNISOLONE ACETATE 10 mg in 1 mL Inactive Ingre...
Route of Administration Topical Local Ocular (intravitreal) Others Product Type OTC Prescription Dosage Form Eye Drops Eye Solutions & Suspensions Capsules & Tablets Gels Ointments Others Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies Regions Covered North America Europe ...
Route of AdministrationOPHTHALMIC Active Ingredient/Active Moiety Ingredient NameBasis of StrengthStrength neomycin sulfate(UNII: 057Y626693) (neomycin - UNII:I16QD7X297)3.5 mg in 1 mL polymyxin B sulfate(UNII: 19371312D4) (polymyxin B - UNII:J2VZ07J96K)10000 in 1 mL ...
1 Distributions of physicochemical parameters among FDA-approved non-oral drugs administered via ophthalmic (A), inhalation (B) and transdermal (C) routes. For each route, the following physicochemical parameters are evaluated: molecular weight (1), number of H-bond donors (2), number of H- ...
For any active agent, the effective amount can be estimated initially either in cell culture assays, e.g., in animal models, such as rat or mouse models. An animal model may also be used to determine the appropriate concentration range and route of administration. Such information can then ...
Adverse systemic reactions associated with the use of topical ophthalmic timolol, chloramphenicol, phenylephrine and cyclopentolate are surveyed, with spec... DFT Fraunfelder,SM Meyer - 《Medical Toxicology & Adverse Drug Experience》 被引量: 60发表: 1987年 Possible allergic reactions to cyclopentolate...
In this review, we discuss the differences in the mechanism of action, route of administration, indication, and efficacy of TNF inhibitors used in the treatment of ocular inflammation.Methods A review of the literature in the PubMed, MEDLINE, and Cochrane databases was conducted to identify ...
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0904-7434 Route of AdministrationOPHTHALMIC Active Ingredient/Active Moiety Ingredient NameBasis of StrengthStrength OFLOXACIN(UNII: A4P49JAZ9H) (OFLOXACIN - UNII:A4P49JAZ9H)OFLOXACIN3 mg in 1 mL ...